BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16134301)

  • 1. [Imaging features of neurofibromatosis type 2].
    Girard N
    J Neuroradiol; 2005 Jun; 32(3):198-203. PubMed ID: 16134301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis.
    Gerber PA; Antal AS; Neumann NJ; Homey B; Matuschek C; Peiper M; Budach W; Bölke E
    Eur J Med Res; 2009 Mar; 14(3):102-5. PubMed ID: 19380279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of multiple tumors in neurofibromatosis type 2 patients.
    Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP
    Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroimaging and clinical spectrum of neurofibromatosis 2.
    Mautner VF; Lindenau M; Baser ME; Hazim W; Tatagiba M; Haase W; Samii M; Wais R; Pulst SM
    Neurosurgery; 1996 May; 38(5):880-5; discussion 885-6. PubMed ID: 8727812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis types 1 and 2.
    Yohay K
    Neurologist; 2006 Mar; 12(2):86-93. PubMed ID: 16534445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary meningioma and neurinoma associated with multiple CNS tumours in a patient with neurofibromatosis type 2.
    Walter J; Kuhn SA; Brodhun M; Reichart R; Kalff R
    Clin Neurol Neurosurg; 2009 Jun; 111(5):454-9. PubMed ID: 19249154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal neurofibrosarcoma in a patient with neurofibromatosis. 2: A case report and review of the literature.
    Chen Y; Diamond AS; Vaheesan KR; Schneider S; Valderrama E
    Pediatr Pathol Mol Med; 2003; 22(5):375-81. PubMed ID: 14692188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 2.
    Slattery WH
    Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging in neurofibromatosis type 2: screening using magnetic resonance imaging.
    Gillespie JE
    Ear Nose Throat J; 1999 Feb; 78(2):102-3, 106, 108-9. PubMed ID: 10089695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
    Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y
    Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polyneuropathy associated with neurofibromatosis].
    Drouet A; Créange A
    Rev Neurol (Paris); 2005 Mar; 161(3):275-83. PubMed ID: 15800448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis 2 in the pediatric age group.
    Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
    Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral vasculopathy in childhood neurofibromatosis type 2: cause for concern?
    Lascelles K; Afridi S; Siddiqui A; Hemingway C; Ferner R; Ganesan V
    Dev Med Child Neurol; 2018 Dec; 60(12):1285-1288. PubMed ID: 29781505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seizures in neurofibromatosis. What is the risk?].
    Drouet A
    Rev Neurol (Paris); 2011 Dec; 167(12):886-96. PubMed ID: 22041820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2.
    Messerli SM; Prabhakar S; Tang Y; Mahmood U; Giovannini M; Weissleder R; Bronson R; Martuza R; Rabkin S; Breakefield XO
    Hum Gene Ther; 2006 Jan; 17(1):20-30. PubMed ID: 16409122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic diversity of neurofibromatosis 2: association with plexiform schwannoma.
    Ishida T; Kuroda M; Motoi T; Oka T; Imamura T; Machinami R
    Histopathology; 1998 Mar; 32(3):264-70. PubMed ID: 9568513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging findings in neurofibromatosis type 1 and 2.
    Rodriguez D; Young Poussaint T
    Neuroimaging Clin N Am; 2004 May; 14(2):149-70, vii. PubMed ID: 15182813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.